Annual accounts receivable:
$101.10M+$13.47M(+15.37%)Summary
- As of today (September 17, 2025), FOLD annual accounts receivable is $101.10 million, with the most recent change of +$13.47 million (+15.37%) on December 31, 2024.
- During the last 3 years, FOLD annual accounts receivable has risen by +$48.43 million (+91.94%).
- FOLD annual accounts receivable is now at all-time high.
Performance
FOLD Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$105.85M+$17.53M(+19.84%)Summary
- As of today (September 17, 2025), FOLD quarterly accounts receivable is $105.85 million, with the most recent change of +$17.53 million (+19.84%) on June 30, 2025.
- Over the past year, FOLD quarterly accounts receivable has increased by +$20.68 million (+24.27%).
- FOLD quarterly accounts receivable is now at all-time high.
Performance
FOLD Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
FOLD Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.4% | +24.3% |
| 3 y3 years | +91.9% | +101.4% |
| 5 y5 years | +203.8% | +145.9% |
FOLD Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.9% | at high | +102.4% |
| 5 y | 5-year | at high | +203.8% | at high | +145.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
FOLD Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $105.85M(+19.8%) |
| Mar 2025 | - | $88.32M(-12.6%) |
| Dec 2024 | $101.10M(+15.4%) | $101.10M(+3.1%) |
| Sep 2024 | - | $98.07M(+15.1%) |
| Jun 2024 | - | $85.17M(+11.4%) |
| Mar 2024 | - | $76.43M(-12.8%) |
| Dec 2023 | $87.63M(+32.4%) | $87.63M(+19.5%) |
| Sep 2023 | - | $73.33M(+15.1%) |
| Jun 2023 | - | $63.72M(-6.5%) |
| Mar 2023 | - | $68.18M(+3.0%) |
| Dec 2022 | $66.20M(+25.7%) | $66.20M(+26.6%) |
| Sep 2022 | - | $52.30M(-0.5%) |
| Jun 2022 | - | $52.56M(+0.3%) |
| Mar 2022 | - | $52.42M(-0.5%) |
| Dec 2021 | $52.67M(+12.3%) | $52.67M(+2.4%) |
| Sep 2021 | - | $51.43M(+4.6%) |
| Jun 2021 | - | $49.17M(+9.4%) |
| Mar 2021 | - | $44.93M(-4.2%) |
| Dec 2020 | $46.92M(+41.0%) | $46.92M(+4.7%) |
| Sep 2020 | - | $44.83M(+4.2%) |
| Jun 2020 | - | $43.04M(+6.1%) |
| Mar 2020 | - | $40.55M(+21.8%) |
| Dec 2019 | $33.28M | $33.28M(-1.3%) |
| Sep 2019 | - | $33.73M(+17.5%) |
| Jun 2019 | - | $28.71M(+25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $22.96M(+4.5%) |
| Dec 2018 | $21.96M(+132.1%) | $21.96M(+54.8%) |
| Sep 2018 | - | $14.19M(-5.9%) |
| Jun 2018 | - | $15.08M(+39.1%) |
| Mar 2018 | - | $10.84M(+14.5%) |
| Dec 2017 | $9.46M(+625.8%) | $9.46M(+58.4%) |
| Sep 2017 | - | $5.97M(+57.8%) |
| Jun 2017 | - | $3.79M(+101.9%) |
| Mar 2017 | - | $1.88M(+43.8%) |
| Dec 2016 | $1.30M(>+9900.0%) | $1.30M(>+9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $293.00K(-38.3%) |
| Jun 2014 | - | $475.00K(+1150.0%) |
| Mar 2014 | - | $38.00K(-95.0%) |
| Dec 2013 | $759.00K(-76.5%) | $759.00K(-64.2%) |
| Sep 2013 | - | $2.12M(+107.1%) |
| Jun 2013 | - | $1.02M(-21.7%) |
| Mar 2013 | - | $1.31M(-59.4%) |
| Dec 2012 | $3.23M(-36.0%) | $3.23M(+1.3%) |
| Sep 2012 | - | $3.18M(-56.0%) |
| Jun 2012 | - | $7.24M(+68.3%) |
| Mar 2012 | - | $4.30M(-14.7%) |
| Dec 2011 | $5.04M | $5.04M(+31.7%) |
| Sep 2011 | - | $3.83M(+93.6%) |
| Jun 2011 | - | $1.98M(-50.2%) |
| Mar 2011 | - | $3.97M |
FAQ
- What is Amicus Therapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual accounts receivable year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly accounts receivable year-on-year change?
What is Amicus Therapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of FOLD is $101.10M
What is the all time high annual accounts receivable for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual accounts receivable is $101.10M
What is Amicus Therapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, FOLD annual accounts receivable has changed by +$13.47M (+15.37%)
What is Amicus Therapeutics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of FOLD is $105.85M
What is the all time high quarterly accounts receivable for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly accounts receivable is $105.85M
What is Amicus Therapeutics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, FOLD quarterly accounts receivable has changed by +$20.68M (+24.27%)